Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 13/20 | 0.45 |
| ▸ | CES1 | P23141 | 12/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL659657 | 0.85 | ALDH1A1 (0.42) | CES2CES1RAB9ALMNAMAPT | |
| SCHEMBL6829479 | 0.82 | CES2 (0.47) | CES2CES1RAB9ALMNAMAPT | |
| SCHEMBL6671451 | 0.82 | CES2 (0.47) | CES2CES1RAB9ALMNAMAPT | |
| SCHEMBL28159138 | 0.81 | CES2 (0.45) | CES2CES1RAB9ALMNAMAPT | |
| SCHEMBL1520841 | 0.81 | CES2 (0.45) | CES2CES1RAB9ALMNAMAPT | |
| SCHEMBL5948412 | 0.78 | CES2 (0.44) | CES2CES1RAB9ALMNAMAPT | |
| SCHEMBL8601696 | 0.78 | RAB9A (0.44) | CES2CES1RAB9ALMNAMAPT | |
| SCHEMBL31120312 | 0.77 | CES2 (0.41) | CES2CES1RAB9ALMNAMAPT | |
| SCHEMBL2942183 | 0.74 | ALDH1A1 (0.40) | LMNAMAPTATMALDH1A1GSK3B | |
| SCHEMBL9212962 | 0.74 | CES2 (0.38) | CES2CES1RAB9ALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104876971-A | Co (II) based metal organic framework as well as preparation method and application thereof | UNIV SHANDONG NORMAL | 2015-09-02 | — | — | CN | claimed |
| US-12180180-B1 | 4-[4,5-bis(4-bromophenyl)-1-hexyl-1H-imidazol-2-yl]isoquinolin-3-ol as an antimicrobial compound | King Faisal University (SA) | 2024-12-31 | — | — | US | disclosed |
| CN-113493445-B | Imidazolyl spiro derivative with aggregation-induced emission property and application thereof | 湖北大学 | 2022-10-28 | — | — | CN | disclosed |
| CN-113493445-A | Imidazolyl spiro derivative with aggregation-induced emission property and application thereof | 湖北大学 | 2021-10-12 | — | — | CN | disclosed |
| CN-104876971-B | Based on Co（Ⅱ）Metal organic frame and preparation method and application | 山东师范大学 | 2017-10-03 | — | — | CN | disclosed |
| CN-105713028-B | A kind of solid-state phase transfer catalyst, preparation method and application based on Cd MOF | 山东师范大学 | 2017-09-26 | — | — | CN | disclosed |
| CN-105713028-A | Novel solid-state phase transfer catalyst based on Cd-MOF, method for preparing novel solid-state phase transfer catalyst and application thereof | 山东师范大学 | 2016-06-29 | — | — | CN | disclosed |
| US-9209408-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-12-08 | — | — | US | disclosed |
| CN-104876971-A | Co (II) based metal organic framework as well as preparation method and application thereof | UNIV SHANDONG NORMAL | 2015-09-02 | — | — | CN | disclosed |
| US-20130261304-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-10-03 | — | — | US | disclosed |
| US-8450485-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-07-12 | — | — | US | disclosed |
| US-8142911-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | CES2 650/4885CES1 638/4885RAB9A 3557/4885 |
| US-12180180-B1 | 4-[4,5-bis(4-bromophenyl)-1-hexyl-1H-imidazol-2-yl]isoquinolin-3-ol as an antimicrobial compound | IRF3, IFNG, TLR4 | CES2 4013/4885CES1 4139/4885RAB9A 1860/4885 |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | CES2 684/4885CES1 744/4885RAB9A 3455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.